The current paradigm for detection of chemotherapy-related cardiotoxicity is symptomatology of congestive heart failure or >10% decline in echo-derived left ventricular ejection fraction (LVEF). 11 This practice has significant limitations because subclinical myocardial damage often occurs in the presence of a stable LVEF. The deterioration in LVEF is frequently only seen late when irreversible damage has already occurred. 12 Myocardial strain (or deformation)
imaging has been proposed as a more sensitive surrogate for assessing myocardial function of cancer survivors. 2 Because large-scale studies to assess the natural history of anthracycline-related cardiotoxicity in the CAYA group are lacking, we aim to systematically summarize the effect of anthracyclines on myocardial deformation in CAYA with cancer or survivors of childhood cancers classified by timing of echocardiographic evaluation.
| ME THODS

| Data sources and searches
A literature search was performed based on recommendations from the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines for systematic reviews. 13 Various combinations of the following terms were searched using PubMed:
strain (or deformation), torsion (or twist), children (or adolescent or young adult), cardiotoxicity (or dysfunction), and anthracyclines (or 
| Data selection, abstraction, synthesis, and analysis
The studies were limited to those focusing on the effects of anthracyclines on myocardial strain in subjects between 1 and 40 years of age, both during and after treatment. Two authors reviewed the titles and abstracts for appropriateness. The articles include observational, cross-sectional, and case-control studies.
Studies of anthracycline exposure in CAYA were divided into three groups based on the duration of anthracycline exposure: during or <1 year after treatment (acute and early-chronic), 1-10 years after treatment (intermediate-late chronic), and ≥10 years after treatment (late-chronic). Because studies of anthracycline toxicity in the CAYA group described the risk of cardiotoxicity as a function of cumulative doxorubicin dosages, the total cumulative anthracycline dose was derived by taking the sum of the calculated doxorubicin-isotoxic dose equivalents 15 and larger sample size were given more weight in calculating the pooled effect size. The heterogeneity among studies was determined using Cochran's Q, 17 which is based on chi-square test with significance defined as P < .10. 18 Heterogeneity was also quanti- 
| Myocardial deformation imaging parameters
Strain, defined as the percentage of change in myocardial wall length, was measured using tissue Doppler imaging (TDI), speckle tracking echocardiography (STE) in both 2D and 3D, or velocity vector imaging (VVI). 16, 20, 21 Longitudinal (LS) and circumferential (CS) strain describe active strain or shortening of the fibers while radial strain (RS) measures passive strain or thickening of the myocardium. 16 Global strain represents the average strain of the entire myocardium for each respective direction, 16 whereas segmental strain refers to shortening or lengthening of a specific portion of the myocardium based on the 16-or 17-segment model. 22 Strain rate (Sr) is the rate of change in strain (reported as strain per second). Rotational mechanics represent myocardial rotation around the axis of the LV at the base and apex. 16 Twist is the absolute apex-to-base difference in rotation reported in degrees while torsion is the base-to-apex difference of the rotation angle divided by the axis of the LV and is reported in degrees per centimeter. Rotation and twisting velocity, reported in degrees per second, are calculated by dividing by the time-in-systole. 16 ,23,24
| RE SULTS
The search returned 131 articles, 23 of which were included in this review ( Figure 1 ). Fourteen papers provided quantitative strain data and were used for the meta-analysis (Figures 2 and 3 ). 
| Reference values for myocardial deformation in CAYA
Differences in strain between groups are described as absolute changes in the strain magnitude with the convention that LS and CS Posttreatment GLS was 6.7%-20% lower compared to control values. [31] [32] [33] All posttreatment GLS values fall outside the reference range 25 except for the 1-to 4-year-old and 10-to 14-year-old groups in Pignatelli et al's paper. 32 The majority of segmental LS values were F I G U R E 2 Standardized mean difference (SMD) and 95% confidence intervals of global longitudinal strain (GLS) between patients at baseline (prior to anthracyclines) and patients within 1 y of anthracycline treatment. The size of the square marker is proportional to the weight assigned to each study in the pooled estimate (diamond) using a random effects model. The weighing is related to the inverse of the standard error (and therefore indirectly to the sample size) reported in the studies. Studies with smaller standard error and larger sample size are given more weight in calculating the pooled effect size. SMD Total (fixed effects) = −0.714; SMD Total (random effects) = −0.788 (both P < .001). Level II evidence. There was no statistically significant difference among the findings of the included 6 articles 27-31,33 (X 2 = 10.32, P = .067), and the inconsistency among included articles was quantified as I 2 = 51.56% (95% CI = 0-80.7). The reported decreases in GLS after treatment based on the 6 included papers [27] [28] [29] [30] [31] 33 are moderately heterogeneous. Doses are reported as mean ± SD unless noted otherwise. a average; b median F I G U R E 3 Standardized mean difference (SMD) and 95% confidence intervals of global longitudinal strain (GLS) between normal controls and patients treated with anthracyclines. The size of the square marker is proportional to the weight assigned to the study in the pooled estimate (diamond) using a random effects model. The weighing is related with the inverse of the standard error (and therefore indirectly to the sample size) reported in the studies. Studies with smaller standard error and larger sample size are given more weight in calculating the pooled effect size. 29, 30 showed that severity of LS abnormalities after chemotherapy varies based on the echocardiographic view; the most significant reduction was seen in the apical long-axis view (40% decrease) with more modest changes in the apical four-chamber and apical two-chamber views (8.7%, and 13% decrease, respectively).
| Circumferential strain
All posttreatment values of GCS 31, 32 were outside the reference range, 25 indicating that GCS in cancer survivors can deteriorate as early as 1 year after treatment. Mavinkurve-Groothuis et al 31 reported a 13% decrease in GCS and a 12% decrease in GCS rate 
| Radial strain
Ganame et al 27 and Mavinkurve-Groothius et al 31 compared baseline and posttreatment GRS, and GRS rate (GRSr) in patients; both studies showed a significant reduction in GRS (39% and 17%, respectively) and GRSr (19% and 12%, respectively) after anthracycline treatment. However, the posttreatment GRS was not significantly different when compared to healthy controls in one of the studies. 31 When compared to reference values, 25 the patients in Ganame et al's 27 study had markedly elevated baseline GRS (74 ± 14%) which decreased after each of the 3 doses of anthracycline administration (56 ± 11% to 52 ± 12% to 45 ± 11%).
| Evaluation of strain 1-10 years posttreatment
Ten papers, 14, 20, 21, 24, [36] [37] [38] [39] [40] [41] nine of which were cross-sectional studies, 14, 21, 24, [36] [37] [38] [39] [40] [41] assessed changes in strain parameters 1-10 years after anthracycline treatment in patients aged 6.9-24 years ( 
TA B L E 2 (Continued)
to the control group. In contrast to the studies mentioned above, Park 
| Circumferential strain
Of the four studies which examined CS, all showed consistently abnormal values in patients 1-10 years postchemotherapy. 20, 24, 38, 41 Yu et al 41 examined transmural strain at the basal, papillary muscle, and apical levels. Patients displayed significantly lower transmural CS gradients at all three levels compared to controls (19%, 9.9%, and 13% lower at the basal, papillary muscle, and apical levels, respectively). Interestingly, the difference in CS between groups was only observed in the endocardial portion, but not in the epicardial portion. This finding was attributed to worsened subendocardial function with preserved subepicardial function.
Cheung et al 24 showed that patients had reduced segmental CS in the anteroseptal, inferoseptal, inferior, and anterior segments as well as 17% reduction in GCS. Similar reductions in the anteroseptal and inferior segments as well as GCS were reported by Toro-Salazar et al 38 ; however, no numerical values were provided.
In regard to Sr, Cheung et al 24 found that patients' GCSr was significantly lower than controls by 15%. Moon et al 20 similarly reported that, compared to controls, GCS was reduced in patients by 8.6% while CSr was decreased by 8.8% for systolic CSr and 14%
for diastolic CSr. The severity of these abnormalities correlated with increasing anthracycline doses.
| Radial strain
Radial strain was evaluated in three studies. 24, 37, 41 In Yu et al's 41 article, RS of the inner segment at the apex, and inner and outer segments of the papillary muscle level were significantly decreased in patients relative to control by 12%, 15%, 21% in the apical inner layer, mid-papillary inner level, mid-papillary outer level, respectively. There was no significant difference in the basal segments or the transmural radial strain in patients compared to controls. In contrast, Cheung et al 24 showed a decrease in GRS of 20% to just above reference values in patients compared to controls. The radial strain difference was present in all segments of myocardium. Statistically significant differences between patients and controls in both peak radial systolic Sr and strain in the inferolateral wall were also reported (no numerical values provided). 
| Torsion and twist
Three papers examined twist, torsion (twist/LV length), and twisting/ untwisting rate. 36, 40, 41 Yu et al 40 examined twist and torsion using 3DSTE and found that both were reduced significantly compared to the healthy cohort (33% and 32% decrease, respectively). Cheung et al 36 examined peak apical and basal rotation, twisting, and untwisting rates, and LV torsion, systolic twisting velocity, and diastolic untwisting velocity. Peak apical rotation and untwisting rate were significantly reduced (24% and 26% reduction, respectively), while basal parameters showed no significant change between patients and controls. All three LV parameters in patients were significantly reduced as compared to controls (peak torsion: 32% reduction, peak systolic twisting velocity: 25% reduction, peak diastolic untwisting velocity: 18% reduction). Yu et al 41 used 2DSTE to examine transmural rotation, twisting, and untwisting velocity at the base and apex. At the base, both the subendocardial and subepicardial rotation, twisting velocity, and untwisting velocity were significantly reduced in patients; hence, there was no significant difference in the transmural gradient between patients and controls. However, at the apex, only the subendocardial layer showed significant changes in rotation, twisting velocity, and untwisting velocity, which led to a significantly reduced transmural rotation gradient when compared to controls (41% reduction).
| Evaluation of strain >10 years posttreatment
Six articles examined strain measurements greater than 10 years after treatment [44] [45] [46] [47] [48] [49] (Table 3) . Time of follow-up ranged from 13.2 to 23.4 years on average. Most studies compared strain measurements between patients treated with anthracyclines to normal controls. [44] [45] [46] One study 49 compared patients to anthracycline naive cancer survivors. Yu et al 48 and Armstrong et al 47 divided patients based on whether they received treatment with anthracyclines only or anthracyclines and mediastinal radiotherapy (MSRT).
| Longitudinal strain
Cheung et al, 44 Mavinkurve-Groothuis et al, 46 and Christiansen et al 49 all showed that GLS was significantly reduced in patients vs controls (between 6.4% and ~7.6% decrease). Changes in strain rate were variable:
TA B L E 3 Summary of studies evaluating patients at >10 y following anthracycline therapy Cheung et al's 44 paper showed no significant change in systolic or dias- 
| Circumferential strain
Abnormal GCS was common in patients treated with anthracycline therapy alone (23%). 47 Cheung et al 44 
| CON CLUS ION
Despite a high degree of heterogeneity among studies using GLS and GCS to compare patients with normal controls, myocardial strain by echocardiography appears to be useful for intra-individual evaluation of subclinical myocardial injury in childhood cancer patients treated with anthracycline therapy. Based on a review of the current body of literature, we found that during and immediately (<1 year) after treatment, the GLS, GCS, and strain rate all show significant changes. Radial strain is decreased compared to baseline; however, these changes are not necessarily different from controls or below the normal range. In the 1-10 years posttreatment, circumferential strain and strain rate are the most consistently abnormal measure- Based of the available published data, it remains unclear which strain measurement is optimal for late follow-up in CAYA cancer survivors. As mentioned above, GCS was abnormal more often than GLS in patients who were >1 year posttreatment, and hence may be an important measurement for long-term follow-up in childhood cancer survivors. This is different from the adult literature where GLS appears to be a more consistent marker across many pathologies including restrictive cardiomyopathy, coronary artery disease, and some valvular disease. 16, 51 We evaluated the consistency of both GLS and GCS abnormalities across studies in patients posttherapy compared to controls. While there was a difference in the SMD when comparing GLS and GCS values in patients following treatment and a control cohort, there was high heterogeneity among studies. The heterogeneity was likely due to different strain tracking methods and software algorithms, as well as variable time-to-evaluation. Lack of standardization in the optimal views used for measuring strain may also explain some of the observed variability in strain measurements between studies.
For example, strain data derived from two apical long-axis views that are foreshortened may not be as accurate as those derived from three apical long-axis views (two-chamber, three-chamber, four-chamber). In summary, while the findings from our metaanalysis are promising, they also suggest that additional studies with larger sample sizes and standardized image acquisition will be helpful for demonstrating value when relating myocardial strain changes to clinical outcomes.
There were limitations encountered in the included studies.
Although strain showed good inter-and intra-observer reliability, certain measurements did show increased variability and may partly be due to inconsistent techniques, vendor-specific strain algorithms, or strain derivation (TDI vs speckle tracking). The
American Society of Echocardiography, the European Association of Cardiovascular Imaging, and industry partners have established a task force to identify sources of variability in strain measurements in order to improve standardization. 52 The sample size of the papers was modest and in some cases images were not analyz- Understanding the natural history of myocardial deformation in CAYA survivors of childhood cancer is imperative for testing of preventive strategies and treatments.
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